Close Menu

Yale

In PNAS this week: immunotherapy for hard-to-treat breast cancers, effects of oncogenic histone H3K36M mutations, and more.

In Nature this week: map of rice quantitative trait nucleotides and their inferred QTN effects, and more.

In PNAS this week: deep learning-based transcription factor prediction approach, simulation study of the Crabtree effect in yeast, and more.

In PNAS this week: variants in Bloom syndrome-related gene increase mesothelioma risk, Streptococcus host transcriptome atlas, and more.

In Genome Biology this week: relapse-linked mutations in T cell acute lymphoblastic leukemia, single-cell atlas of human tissue transcriptomes, and more.

Developed by researchers at Yale University, the method, called deterministic barcoding in tissue sequencing, can map thousands of genes at 10 micron resolution.

In PNAS this week: role of USF2 in refractory rheumatoid arthritis, thymus-associated cells may show up post-thymectomy in myasthenia gravis patients, and more.

The partners aim to refine a saliva-based SARS-CoV-2 test developed by Yale that received Emergency Use Authorization from the FDA earlier this year.

Yale University researchers have developed a file-format manipulation approach to block access to certain variants to protect participants' sensitive information.

In Genome Biology this week: mouse model for determining immunotherapy response, genomic changes that occur with non-small cell lung cancer metastasis, and more.

Pages

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.